However, comparison of common checkpoints PD–L1 (CD274), PD1 (PDCD1), CTLA4, and LAG3 between male and female patients reveled that sex is not the main factor for the prediction of response to immune checkpoint inhibitors in STS. This evidence concerns the gene PDCD1 and telomere syndrome.